Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
This platform ensures high drug accumulation and easy excretion in colorectal tumors, thereby improving biosafety and targeting capabilities
The membranes were incubated with primary antibodies LC3A/B (1:1000 dilution, #4108, Cell Signaling Technology, Massachusetts, United States), p62 (1:2000 dilution, ab56416, Abcam, Massachusetts, United States), PINK1 (1:1000 dilution, 23274-1-AP, Proteintech Group, Illinois, United States), Parkin (1:1000 dilution, ab15954, Abcam, Massachusetts, United States), and GAPDH (1:2000 dilution, #2118, Cell Signaling Technology, Massachusetts, United States) overnight at 4C after blocking the membranes with 5% nonfat milk for 1 h, and then incubated with the appropriate IRDye-conjugated secondary antibody (1:10000 dilution, IRDye 800 CW goat anti-rabbit or IRDye 680RD goat anti-mouse, LI-COR Biosciences, Nebraska, United States) and imaged using the LI-COR Odyssey
"Updated: GSK moves to shutter Sirtris' Cambridge office, integrate R&D"
Development of sesamol carbamate-L-phenylalanine prodrug targeting L-Type Amino Acid Transporter1 (LAT1) as a potential antiproliferative agent against melanoma
How Long Does the Injection Take
En ocasiones, se usa para confirmar un cariotipo previo
US$ 28.80
US$ 23.95
US$ 27.85
US$ 21.96
US$ 23.60
